Timeseer.AI and QbD Group Forge Strategic Partnership to Enhance Sensor Data Quality in Life Sciences

QbD Group, service partner in the life sciences sector, and Timeseer.AI, a data solution provider, have signed a strategic partnership. Reliable data is key in any industry, but for life sciences and medical devices companies, sensor data is a key component to drive operational excellence and to accelerate the digital transformation. The better the performance based on this trustworthy data, the better the patients’ health care at the end of the value chain.

Timeseer.AI is a growing top solution provider for data quality optimization. Their platform harnesses the power of advanced artificial intelligence to detect, prioritize, and investigate sensor data quality issues. This way, the experts can notify possible issues before these significantly impact operations or critical decisions. In parallel, the QbD Group’s team offers knowledge and tailored (software) services and solutions in development, clinical, regulatory & compliance, production, and distribution for companies active in pharma, biotech, digital health, medical devices, and in vitro diagnostics.

In addition to its deep industry knowledge, QbD Group brings to the table its specialized capabilities in the implementation and validation of software and AI/ML technologies. This ensures that companies not only adopt new technologies but also meet the rigorous regulatory standards required in the life sciences sector. By leveraging QbD’s expertise in Software and AI/ML Validation, clients gain the assurance that their digital tools are not just innovative but are also compliant and reliable.

Bert Baeck, CEO of Timeseer.AI, says:

“The combination of the QbD Group’s expertise in the industry, and Timeseer.AI’s sensor data quality platform, provides a unique solution to ensure high-quality and reliable sensor data. This will counter the well-known need within pharmaceutical companies to improve and increase critical validation, and the reliability of processes. Additionally, it improves and increases the digitalization transformation within the industry.”

Bart Van Acker, CEO of the QbD Group, adds:

“By putting Timeseer.AI’s advanced technology together with our in-depth industry knowledge and our specialized capabilities in software and AI/ML validation, we are setting a new standard for sensor data quality. This collaboration is not only strategic, but -in line with what the QbD Group stands for-, a commitment to operational excellence and therefore also to the health and well-being of patients worldwide.”

Since 2011, the QbD Group has been providing solutions for product development and manufacturing within the life sciences sector. The company offers skills and expertise to solve complex problems in quality assurance, validation & qualification, regulatory affairs, clinical studies, lab services, software solutions & services, Vigilance, and business & communication for companies active in the biotech, pharma, digital health, medical device & IVD industries. The QbD Group is headquartered in Belgium and has over 600 consultants worldwide. For more information, visit the website at https://qbdgroup.com, or the social media channels (LinkedIn, Facebook, Instagram).

About Timeseer.AI

The Timeseer.AI employees together have more than 80 years of relevant data experience. Therefore, Timeseer.AI understands the complexity of turning raw data into high-quality, reliable data. The company’s software does the heavy lifting and empowers data teams to detect, analyze and augment data quality issues, and can resolve them. For more information, visit the website at https://www.timeseer.ai.